Article Details

Roche's Actemra/RoActemra approved for treatment of severe COVID-19 in Europe

Retrieved on: 2021-12-07 21:36:32

Tags for this article:

Click the tags to see associated articles and topics

Roche's Actemra/RoActemra approved for treatment of severe COVID-19 in Europe. View article details on HISWAI: https://www.biopharma-reporter.com/Article/2021/12/07/Roche-s-Actemra-RoActemra-approved-for-treatment-of-severe-COVID-19-in-Europe

Excerpt

Roche received Emergency Use Authorization for the monoclonal antibody against COVID-19 from the US Food and Drug Administration (FDA) in June; ...

Article found on: www.biopharma-reporter.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up